Month: January 2023
FDA Approves Adjuvant Pembrolizumab for Non-Small Cell Lung Cancer Treatment
The US Food and Drug Administration has approved Pembrolizumab for adjuvant treatment following resection and platinum-based chemotherapy in patients with [...]
Researchers develop AI Tool, Sybil, to Predict Lung Cancer Risk
A new study has been conducted by investigators from the Mass General Cancer Center in collaboration with researchers at the Massachusetts Institute of [...]
Sarunashi Fruit May Inhibit Lung Cancer Growth, Study Finds
The researchers from Okayama University in Japan have found evidence that ingesting juice from sarunashi fruit can help prevent and reduce lung cancer via a [...]
Novocure and Zai Lab Announces Pivotal LUNAR Study in NSCLC
Zai Lab Limited and Novocure have announced the LUNAR study met its primary endpoint. It demonstrates statistically significant and clinically meaningful [...]
Lung Cancer Increased by 5% in Last Two Years: Central Govt India
The disease of lung cancer is a significant health concern all around the world. Its alarming rise is becoming serious issue among people of all ages. [...]